Robert Ys Cheng

5PUBLICATIONS
28CO-AUTHORS
Epidemiological modellingMolecular targetsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 11, 2025
RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. Molecules 2019, 24, 3722.

Sana Waheed, Robert Ys Cheng, Yovanni Casablanca

|Oct 02, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.

Lisa A Ridnour, William F Heinz, Robert Y S Cheng

|Jun 19, 2024
NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.

Leandro L Coutinho, Elise L Femino, Ana L Gonzalez

|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome.

Robert Y S Cheng, Lisa A Ridnour, Adelaide L Wink

|Feb 25, 2023
Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells.

Robert Y S Cheng, Sandra Burkett, Stefan Ambs

Pageof 1

Frequent Collaborators

4 joint publications

Lisa A Ridnour

3 joint publications

Stefan Ambs

3 joint publications

William F Heinz

3 joint publications

Stephen J Lockett